Cargando…

The Role of Cardiac Fibrosis in Diabetic Cardiomyopathy: From Pathophysiology to Clinical Diagnostic Tools

Diabetes mellitus (DM) is a chronic metabolic disorder characterized by hyperglycemia due to inadequate insulin secretion, resistance, or both. The cardiovascular complications of DM are the leading cause of morbidity and mortality in diabetic patients. There are three major types of pathophysiologi...

Descripción completa

Detalles Bibliográficos
Autores principales:	Pan, Kuo-Li, Hsu, Yung-Chien, Chang, Shih-Tai, Chung, Chang-Min, Lin, Chun-Liang
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10218088/ https://www.ncbi.nlm.nih.gov/pubmed/37239956 http://dx.doi.org/10.3390/ijms24108604

Ejemplares similares

Knockout of KLF10 Ameliorated Diabetic Renal Fibrosis via Downregulation of DKK-1
por: Hsu, Yung-Chien, et al.
Publicado: (2022)

Diabetic cardiomyopathy: from the pathophysiology of the cardiac myocytes to current diagnosis and management strategies
por: Voulgari, Christina, et al.
Publicado: (2010)

Diabetic cardiomyopathy: pathophysiology and clinical features
por: Miki, Takayuki, et al.
Publicado: (2012)

The Diabetic Cardiomyopathy: The Contributing Pathophysiological Mechanisms
por: Salvatore, Teresa, et al.
Publicado: (2021)

Pathophysiology and therapeutic potential of cardiac fibrosis
por: Hara, Hironori, et al.
Publicado: (2017)

Cardiac fibrosis and dysfunction in experimental diabetic cardiomyopathy are ameliorated by alpha-lipoic acid
por: Li, Chun-jun, et al.
Publicado: (2012)

Central role of cardiac fibroblasts in myocardial fibrosis of diabetic cardiomyopathy
por: Cheng, Yanan, et al.
Publicado: (2023)

Diabetic cardiomyopathy: Pathophysiology, theories and evidence to date
por: Athithan, Lavanya, et al.
Publicado: (2019)

Single-cell transcriptomic profiles in the pathophysiology within the microenvironment of early diabetic kidney disease
por: Tsai, Yi-Chun, et al.
Publicado: (2023)

Takotsubo cardiomyopathy: Pathophysiology and role of cardiac biomarkers in differential diagnosis
por: Gopalakrishnan, Prabhakaran, et al.
Publicado: (2017)

Trichostatin A ameliorates renal tubulointerstitial fibrosis through modulation of the JNK-dependent Notch-2 signaling pathway
por: Tung, Chun-Wu, et al.
Publicado: (2017)

Recent Advances in Diabetic Kidney Diseases: From Kidney Injury to Kidney Fibrosis
por: Hung, Peir-Haur, et al.
Publicado: (2021)

Mechanism of Yangxinshi Intervention on Cardiac Fibrosis in Diabetic Cardiomyopathy Based on Network Pharmacology
por: Kuang, Jiangying, et al.
Publicado: (2022)

Pathophysiology and Treatment of Diabetic Cardiomyopathy and Heart Failure in Patients with Diabetes Mellitus
por: Nakamura, Kazufumi, et al.
Publicado: (2022)

Therapeutic Potential of Extracts from Macaranga tanarius (MTE) in Diabetic Nephropathy
por: Hsu, Yung-Chien, et al.
Publicado: (2023)

Liver X Receptor/Retinoid X Receptor Pathway Plays a Regulatory Role in Pacing‐Induced Cardiomyopathy
por: Lin, Yu‐Sheng, et al.
Publicado: (2019)

FTZ Ameliorates Diabetic Cardiomyopathy by Inhibiting Inflammation and Cardiac Fibrosis in the Streptozotocin-Induced Model
por: Wang, Lexun, et al.
Publicado: (2021)

COVID-19: Pathophysiology and implications for cystic fibrosis, diabetes and cystic fibrosis-related diabetes
por: Mason, Kelly, et al.
Publicado: (2021)

Identification of target genes in cardiomyopathy with fibrosis and cardiac remodeling
por: Zhao, Jianquan, et al.
Publicado: (2018)

The feasibility and diagnostic accuracy by multiple cardiac biomarkers in emergency chest pain patients: a clinical analysis to compare 290 suspected acute coronary syndrome cases stratified by age and gender in Taiwan
por: Hung, Chung-Lieh, et al.
Publicado: (2016)

Diagnostic approaches for diabetic cardiomyopathy
por: Lorenzo-Almorós, A., et al.
Publicado: (2017)

Pathophysiological Gaps, Diagnostic Challenges, and Uncertainties in Cardiac Sarcoidosis
por: Ueberham, Laura, et al.
Publicado: (2023)

Pathophysiology, Clinical Characteristics of Diabetic Cardiomyopathy: Therapeutic Potential of Natural Polyphenols
por: Atale, Neha, et al.
Publicado: (2020)

Cystic Fibrosis–Related Diabetes: Pathophysiology and Therapeutic Challenges
por: Kelsey, Ryan, et al.
Publicado: (2019)

Forskolin Protected against Streptozotocin-Induced Diabetic Cardiomyopathy via Inhibition of Oxidative Stress and Cardiac Fibrosis in Mice
por: Zhang, Xu, et al.
Publicado: (2021)

Empagliflozin and Liraglutide Differentially Modulate Cardiac Metabolism in Diabetic Cardiomyopathy in Rats
por: Trang, Nguyen Ngoc, et al.
Publicado: (2021)

HDAC Inhibition Modulates Cardiac PPARs and Fatty Acid Metabolism in Diabetic Cardiomyopathy
por: Lee, Ting-I, et al.
Publicado: (2016)

Cardiac Sodium Channel Dysfunction and Dilated Cardiomyopathy: A Contemporary Reappraisal of Pathophysiological Concepts
por: Asatryan, Babken
Publicado: (2019)

Cannabinoid 1 Receptor Promotes Cardiac Dysfunction, Oxidative Stress, Inflammation, and Fibrosis in Diabetic Cardiomyopathy
por: Rajesh, Mohanraj, et al.
Publicado: (2012)

Matrine suppresses cardiac fibrosis by inhibiting the TGF-β/Smad pathway in experimental diabetic cardiomyopathy
por: Zhang, Yong, et al.
Publicado: (2018)

Atrial Cardiomyopathy: Pathophysiology and Clinical Consequences
por: Goette, Andreas, et al.
Publicado: (2021)

Insights Into Genetics and Pathophysiology of Arrhythmogenic Cardiomyopathy
por: Gerull, Brenda, et al.
Publicado: (2021)

Evidence of Ventricular Arrhythmogenicity and Cardiac Sympathetic Hyperinnervation in Early Cirrhotic Cardiomyopathy
por: Liu, Shin-Huei, et al.
Publicado: (2021)

Proteomic Insights into Cardiac Fibrosis: From Pathophysiological Mechanisms to Therapeutic Opportunities
por: Qi, Ruiqiang, et al.
Publicado: (2022)

Impact of Gout on Left Atrial Function: A Prospective Speckle-Tracking Echocardiographic Study
por: Pan, Kuo-Li, et al.
Publicado: (2014)

Immune Modulation by Myeloid-Derived Suppressor Cells in Diabetic Kidney Disease
por: Hsieh, Ching-Chuan, et al.
Publicado: (2022)

Long noncoding RNA Crnde attenuates cardiac fibrosis via Smad3‐Crnde negative feedback in diabetic cardiomyopathy
por: Zheng, Dezhi, et al.
Publicado: (2019)

The Histone Demethylase Inhibitor GSK-J4 Is a Therapeutic Target for the Kidney Fibrosis of Diabetic Kidney Disease via DKK1 Modulation
por: Hung, Peir-Haur, et al.
Publicado: (2022)

Ventricular arrhythmias in nonischemic cardiomyopathy
por: Chung, Fa‐Po, et al.
Publicado: (2018)

Inhibitory effects of armepavine against hepatic fibrosis in rats
por: Weng, Ting-Chun, et al.
Publicado: (2009)

Cannot write session to /tmp/vufind_sessions/sess_r01e6ad0kofi89677qf3alited